Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Eisai Co Ltd

Recent news which mentions Eisai Co Ltd

5 things to know before the stock market opens Tuesday
Tags Politics Economy Technology
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags US: News Biotechnology Business News
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags Biogen Inc Health care industry Medicare health plans
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Eisai Co Ltd Business Biotech and Pharmaceuticals
From CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
Tags Biogen Inc Market Insider Economy
From CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
Tags Asia Markets Eisai Co Ltd Biotech and Pharmaceuticals
From CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags Biotechnology World News US: News
From CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
Tags U/S/ Economy Business News Biotechnology
From CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags U/S/ Economy Biotechnology US: News
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Breaking News: Business Politics Alzheimer's disease
From CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
Tags Breaking News: Business Politics Policy
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags Biotechnology World News Quanterix Corp
From CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Tags Pandemics Eisai Co Ltd Business
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Health & Science Health care industry Biogen Inc
From CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Tags Health & Science Pharmaceuticals Biogen Inc
From CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
Tags Eli Lilly and Co Eisai Co Ltd Biotech and Pharmaceuticals
From CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
Tags Politics Policy Epidemics
From CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
Tags Coronavirus Health & Science US Top News and Analysis
From CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
Tags US Top News and Analysis Health & Science Coronavirus
From CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
Tags Breaking News: Business Policy Epidemics
From CNBC.com News
Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
Tags Biogen Inc Health care industry US Top News and Analysis
From CNBC.com News
FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial
Tags Pandemics US Economy Eisai Co Ltd
From CNBC.com News
Stocks making the biggest moves premarket: Tesla, Nutanix, Meta and more
Tags 3M Co Biogen Inc Market Insider
From CNBC.com News
Stocks making the biggest moves premarket: Biogen, Thor Industries, Lyft and more
Tags Breaking News: Markets Eisai Co Ltd Stock markets
From CNBC.com News
Why Biogen's Alzheimer's drug Aduhelm is so controversial
Tags US: News Health Insurance Business News
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.